23 May 2013

Plethora treatment wins NHS approval

15/04/2011 Ben Jaglom

Specialist pharmaceutical concern Plethora Solutions Holdings (PLE) says it has won approval for its vaginal dryness treatment Hyalofemme from the NHS for prescription.

The agreement means that doctors in the UK will now be able to write prescriptions for Hyalofemme for the first time for atrophic vaginitis, commonly referred to as vaginal dryness. Traditional treatments involve the use of hormonal creams containing estrogen, but such creams are often inappropriate for cancer patients, who often suffer vaginal dryness as a side effect of cancer treatment.

Chairman Bill Robinson remarks the decision by the NHS should 'increase the commercial value of our pipeline by exploiting products secured last year'. He adds that the release of Hyalofemme is an 'important treatment' for atrophic vaginitis.

Following the announcement analysts at house broker Daniel Stewart held their forecasts of a year-end loss of £1.3 million (2010: loss of £1.5 million) on revenue up £100,000 to £1.2 million. They have pencilled in a loss per share of 2.5p for 2011 and a further loss of 3.4p a share for 2012.

Shares in Plethora were up 0.25p this morning following the announcement to 7.5p, the price at which Growth Company Investor recommended them earlier this month. A good sign for the company's prospects, Hyalofemme will be prescribed both for those being treated for cancer and women going through the menopause. We therefore reiterate our speculative buy rating.

Tags: AIM market, Menopause, Pharma, Plethora Solutions Holdings, Urology Company, Vaginal dryness

Beat the market


1. View our terms and conditions here

The Share Centre

Stocks & Shares ISA

Onine Tools To Make Investments

Easy And Low Admin Fee

The latest company webcasts

Live and pre recorded video & audio updates from companies on their latest news, results & AGMs through interviews and presentations. Find out more.

Achieve impressive returns on the go

Gain instant access to some of the best-performing and fastest growing companies in the small cap arena. Sign up NOW!

Director's Pay 2013

The annual Directors' Pay on AIM Report is the most comprehensive review of directors' renumeration on AIM available. It's ideal for benchmarking your team's, your organisation's and your own salary. The full report is available to order in PDF format for £350 (+VAT). Order report here

Cash Shells 2013

This research provides a comprehensive overview of cash shells, companies that have become a significant feature on the Main Market, AIM and PLUS landscape. The full report (out June 2013) is now available to pre-order in PDF format for £295 (+VAT). Contact us for more info

M&A on AIM 2012

This new report examines valuation metrics, cash balances and financial performance to provide dealmakers with all the tools they need to pinpoint undervalued companies on AIM. The full report is available to order in PDF format for £295 (+VAT). Order report here

Coverage and tips for AIM and Small Caps

Informative features and research on fast-growing companies, with AIM market and small cap tips, news on growth stocks, penny shares and junior stock market companies. Regular share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

If you're interested in business tax updates visit our specialist tax guide website.

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Quindell provides technology services to the insurance industry

Quindell signs five-year deal 22/05/2013

Software outsourcing specialist Quindell Portfolio (LON:QPP) has signed a five-year deal with a UK motor insurer, initially worth £3.5 million.

Tags: Contract win, Insurance, Software & Computer Services

Magnolia adds 11 wells 21/05/2013

US-focused oil and gas explorer Magnolia Petroleum (LON:MAGP) has decided to participate in another 11 wells across North Dakota and Oklahoma.

Tags: Oil & Gas, Oil & gas on AIM, USA

Quixant joins AIM 21/05/2013

Supplier of computing platforms for gaming and slot machines Quixant (LON:QXT) has joined London's junior market.

Tags: AIM newcomer, Computer services, Gaming

Xcite sells data 20/05/2013

North Sea-focused Xcite Energy (LON:XER) will sell off data worth US$15 million (£9.9 million) regarding its Bentley 9/03b-6, 6Z well.

Tags: North Sea, Oil & Gas, Oil & gas on AIM

Vatukoula takes £4.5m investment 20/05/2013

Fiji-focused Vatukoula Gold Mines (LON:VGM) will receive £4.5 million from SCD Energy in exchange for a 19.2 per cent stake in the company.

Tags: Fiji, Gold, Mining

Snoozebox to restructure 17/05/2013

Shares in temporary hotel company Snoozebox Holdings (LON:ZZZ) tumbled after it was announced the business will undergo a reorganisation.

Tags: Hotel business, Restructuring, Strategic review

More News